Federal Register / Vol. 69, No. 191 / Monday, October 4, 2004 / Notices 59237

4770 Buford Highway, NE., MS K–10, 

Atlanta, GA 30341, telephone: (770) 

448–5035, e-mail: sfe9@cdc.gov.

For financial, grants management, or 

budget assistance, contact: Tiffney 

Esslinger, Grants Management 

Specialist, CDC Procurement and Grants 

Office, 2920 Brandywine Road, Atlanta, 

GA 30341, telephone: (770) 488–2686, email: tesslinger@cdc.gov.

VIII. Other Information 

VIII.A. NDEP Workgroup Member 

Position Description and Requirements 

Workgroup members serve as 

advisors/consultants for the 

development of NDEP materials, and 

implement strategic intervention 

activities for the NDEP program through 

their NDEP partner organizations. In 

addition, workgroup members serve as 

conduits for promoting the NDEP 

messages and the principles of NDEP. 

Workgroup members participate on 

conference calls, face-to-face meetings 

and the annual Partnership Network 

conference. 

Workgroup membership roles and 

responsibilities include a commitment 

to do the following: 

• Represent an organization invited to 

participate as an NDEP partner. 

• Notify the workgroup chair if the 

workgroup member no longer represents 

the NDEP partner organization or if the 

organization selects another 

representative. 

• Communicate with the organization 

which the member represents about 

NDEP campaigns and activities. 

• Communicate with NDEP about 

members’ organizational activities in 

support of the NDEP goals and 

objectives.

• Participate in workgroup 

conference calls. In most workgroups 

this represents a commitment of one 

hour monthly. 

• Participate in face-to-face meetings, 

which usually will include one 

workgroup meeting and one Partnership 

Network meeting annually. It is not 

acceptable to invite a substitute to 

participate on a call or at a meeting if 

the NDEP member is not available. 

• Facilitate partnerships that promote 

NDEP activities. 

• Serve as a spokesperson for NDEP. 

• Encourage networking in 

professional associations and 

organizations to promote NDEP. 

• Assist with language translation or 

review of translated materials (if needed 

and applicable). 

• Provide feedback and input for 

materials development. 

• Contribute to NDEP’s overall 

evaluation effort by reporting back to 

NDEP staff about activities promoting, 

disseminating or implementing NDEP 

campaigns and interventions. 

VIII.B. CDC Division of Diabetes 

Translation National Objectives 

1. By 2008, demonstrate success in 

achieving an increase in the percentage 

of people with diabetes in your 

jurisdiction who receives the 

recommended foot exams. 

2. By 2008, demonstrate success in 

achieving an increase in the percentage 

of people with diabetes in your 

jurisdiction who receives the 

recommended eye exams. 

3. By 2008, demonstrate success in 

achieving an increase in the percentage 

of people with diabetes in your 

jurisdiction who receive the 

recommended vaccinations (influenza 

and pneumococcal). 

4. By 2008, demonstrate success in 

achieving an increase in the percentage 

of people with diabetes in your 

jurisdiction who receives the 

recommended A1C tests. 

5. By 2008, demonstrate success in 

reducing health disparities for high-risk 

populations with respect to diabetes 

prevention and control. 

6. By 2008, demonstrate success in 

linking to programs for promotion of 

wellness and physical activity, weight 

and blood pressure control and smoking 

cessation for people with diabetes. 

To find out more about the National 

Diabetes Education Program (NDEP), 

visit the following Web sites at:

http://www.ndep.nih.gov, http://

www.cdc.gov/diabetes/ndep, http://

www.betterdiabetescare.nih.gov, http://

www.diabetesatwork.org.

To find out more about the CDC 

Division of Diabetes Translation, visit 

the Web site at: http://www.cdc.gov/

diabetes.

Dated: September 28, 2004. 

William P. Nichols, 

Acting Director, Procurement and Grants 

Office, Centers for Disease Control and 

Prevention.

[FR Doc. 04–22259 Filed 10–1–04; 8:45 am] 

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Diseases Transmitted Through the 

Food Supply

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS).

ACTION: Notice of annual update of list 

of infectious and communicable 

diseases that are transmitted through 

handling the food supply and the 

methods by which such diseases are 

transmitted. 

SUMMARY: Section 103(d) of the 

Americans with Disabilities Act of 1990, 

Pub. L. 101–336, requires the Secretary 

to publish a list of infectious and 

communicable diseases that are 

transmitted through handling the food 

supply and to review and update the list 

annually. The Centers for Disease 

Control and Prevention (CDC) published 

a final list on August 16, 1991 (56 FR 

40897) and updates on September 8, 

1992 (57 FR 40917); January 13, 1994 

(59 FR 1949); August 15, 1996 (61 FR 

42426); September 22, 1997 (62 FR 

49518–9); September 15, 1998 (63 FR 

49359), September 21, 1999 (64 FR 

51127); September 27, 2000 (65 FR 

58088), September 10, 2001 (66 FR 

47030), September 27, 2002 (67 FR 

61109) and November 6, 2003 (68 FR 

62809). No new information that would 

warrant additional changes has been 

received; therefore the list, as set forth 

in the last update and below, remains 

unchanged.

EFFECTIVE DATE: October 4, 2004.

FOR FURTHER INFORMATION CONTACT: Dr. 

Art Liang, National Center for Infectious 

Diseases, Centers for Disease Control 

and Prevention (CDC), 1600 Clifton 

Road, NE., Mailstop G–24, Atlanta, 

Georgia 30333, telephone (404) 639–

2213

SUPPLEMENTARY INFORMATION: Section 

103(d) of the Americans with 

Disabilities Act of 1990, 42 U.S.C. 

12113(d), requires the Secretary of 

Health and Human Services to: 

1. Review all infectious and 

communicable diseases which may be 

transmitted through handling the food 

supply; 

2. Publish a list of infectious and 

communicable diseases which are 

transmitted through handling the food 

supply; 

3. Publish the methods by which such 

diseases are transmitted; and, 

4. Widely disseminate such 

information regarding the list of 

diseases and their modes of 

transmissibility to the general public. 

Additionally, the list is to be updated 

annually. 

Since the last publication of the list 

on November 6, 2003 (68 FR 62809), 

CDC has received no information to 

indicate that additional unlisted 

diseases are transmitted through 

handling the food supply. Therefore, the 

list set forth below is unchanged from 

59238 Federal Register / Vol. 69, No. 191 / Monday, October 4, 2004 / Notices 

* Kauffmann-White scheme for designation of 

Salmonella serotypes

the list published in the Federal 

Register on November 6, 2003. 

I. Pathogens Often Transmitted by Food 

Contaminated by Infected Persons Who 

Handle Food, and Modes of 

Transmission of Such Pathogens 

The contamination of raw ingredients 

from infected food-producing animals 

and cross-contamination during 

processing are more prevalent causes of 

foodborne disease than is contamination 

of foods by persons with infectious or 

contagious diseases. However, some 

pathogens are frequently transmitted by 

food contaminated by infected persons. 

The presence of any one of the 

following signs or symptoms in persons 

who handle food may indicate infection 

by a pathogen that could be transmitted 

to others through handling the food 

supply: diarrhea, vomiting, open skin 

sores, boils, fever, dark urine, or 

jaundice. The failure of food-handlers to 

wash hands (in situations such as after 

using the toilet, handling raw meat, 

cleaning spills, or carrying garbage, for 

example), wear clean gloves, or use 

clean utensils is responsible for the 

foodborne transmission of these 

pathogens. Non-foodborne routes of 

transmission, such as from one person 

to another, are also major contributors 

in the spread of these pathogens. 

Pathogens that can cause diseases after 

an infected person handles food are the 

following:

Noroviruses 

Hepatitis A virus 

Salmonella Typhi*

Shigella species

Staphylococcus aureus

Streptococcus pyogenes

II. Pathogens Occasionally Transmitted 

by Food Contaminated by Infected 

Persons Who Handle Food, But Usually 

Transmitted by Contamination at the 

Source or in Food Processing or by 

Non-foodborne Routes 

Other pathogens are occasionally 

transmitted by infected persons who 

handle food, but usually cause disease 

when food is intrinsically contaminated 

or cross-contaminated during processing 

or preparation. Bacterial pathogens in 

this category often require a period of 

temperature abuse to permit their 

multiplication to an infectious dose 

before they will cause disease in 

consumers. Preventing food contact by 

persons who have an acute diarrheal 

illness will decrease the risk of 

transmitting the following pathogens:

Campylobacter jejuni

Cryptosporidium parvum

Entamoeba histolytica

Enterohemorrhagic Escherichia coli

Enterotoxigenic Escherichia coli

Giardia lamblia

Nontyphoidal Salmonella

Taenia solium

Vibrio cholerae 01 

Yersinia enterocolitica

References 

1. World Health Organization. Health 

surveillance and management 

procedures for food-handling personnel: 

report of a WHO consultation. World 

Health Organization technical report 

series; 785. Geneva: World Health 

Organization, 1989. 

2. Frank JF, Barnhart HM. Food and 

dairy sanitation. In: Last JM, ed. MaxcyRosenau public health and preventive 

medicine, 12th edition. New York 

Appleton-Century-Crofts, 1986:765–806. 

3. Bennett JV, Holmberg SD, Rogers 

MF, Solomon SL. Infectious and 

parasitic diseases. In: Amler RW, Dull 

HB, eds. Closing the gap: the burden of 

unnecessary illness. New York: Oxford 

University Press, 1987:102–114. 

4. Centers for Disease Control and 

Prevention. Locally acquired 

neurocysticercosis—North Carolina, 

Massachusetts, and South Carolina, 

1989–1991. MMWR 1992; 41:1–4. 

5. Centers for Disease Control and 

Prevention. Foodborne Outbreak of 

Cryptosporidiosis-Spokane, 

Washington, 1997. MMWR 1998; 47:27.

Dated: September 24, 2004. 

James D. Seligman, 

Associate Director for Program Services, 

Centers for Disease Control and Prevention 

(CDC).

[FR Doc. 04–22260 Filed 10–1–04; 8:45 am] 

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES

Food and Drug Administration

Clinical Pharmacology Subcommittee 

of the Advisory Committee for 

Pharmaceutical Science; Notice of 

Meeting

AGENCY: Food and Drug Administration, 

HHS.

ACTION: Notice.

This notice announces a forthcoming 

meeting of a public advisory committee 

of the Food and Drug Administration 

(FDA). The meeting will be open to the 

public.

Name of Committee: Clinical 

Pharmacology Subcommittee of the 

Advisory Committee for Pharmaceutical 

Science.

General Function of the 

Subcommittee: To provide advice and 

recommendations to the agency on 

FDA’s regulatory issues.

Date and Time: The meeting will be 

held on November 3, 2004, from 8 a.m. 

to 5:30 p.m., and on November 4, 2004, 

from 8 a.m. to 1:30 p.m.

Location: Center for Drug Evaluation 

and Research Advisory Committee 

Conference Room, rm. 1066, 5630 

Fishers Lane, Rockville, MD.

Contact Person: Hilda Scharen, Center 

for Drug Evaluation and Research (HFD–

21), Food and Drug Administration, 

5600 Fishers Lane (for express delivery, 

5630 Fishers Lane, rm. 1093), Rockville, 

MD 20857, 301–827–7001, FAX 301–

827–6776, e-mail: 

SCHARENH@cder.fda.gov or FDA 

Advisory Committee Information Line, 

1–800–741–8138 (301–443–0572) in the 

Washington, DC area), code 

3014512539. Please call the Information 

Line for up-to-date information on this 

meeting.

Agenda: On November 3, 2004, the 

subcommittee will: (1) Receive topic 

updates for ongoing FDA activities 

previously presented to the 

subcommittee; (2) discuss and provide 

comments on the evidence for updating 

labels of approved drugs to include 

integrating pharmacogenetic, 

pharmacokinetic, and prognostic 

biomarkers for the purpose of 

optimizing therapeutic response and 

reducing risks of toxicity; and (3) 

discuss and provide comments on 

metabolism- and transporter-based drugdrug interactions included as 

recommendations in a draft guidance for 

industry being prepared by FDA. On 

November 4, 2004, the subcommittee 

will discuss and provide comments on 

a new critical path project related to 

general aspects of the transition of 

biomarkers to surrogate endpoints, with 

a focus on planning and process, rather 

than on specific biomarkers or surrogate 

endpoints.

Procedure: Interested persons may 

present data, information, or views, 

orally or in writing, on issues pending 

before the subcommittee. Written 

submissions may be made to the contact 

person by October 25, 2004. Oral 

presentations from the public will be 

scheduled between approximately 12:30 

p.m. and 1 p.m. on November 3, 2004, 

and between 1 p.m. and 1:30 p.m. on 

November 4, 2004. Time allotted for 

each presentation may be limited. Those 

desiring to make formal oral 

presentations should notify the contact 

person before October 25, 2004, and 

submit a brief statement of the general 

nature of the evidence or arguments 

they wish to present, the names and